InvestorsHub Logo
Followers 27
Posts 2923
Boards Moderated 0
Alias Born 11/07/2010

Re: JB51 post# 7496

Thursday, 08/04/2016 12:22:07 PM

Thursday, August 04, 2016 12:22:07 PM

Post# of 12606
VIVITROL is injectable naltrexone produced by Alkermes plc (ALKS). ALKS has a 7.5 billion dollar market cap and is estimated to do about 185mm in net sales this year of VIVITROL. If BICX could produce a better version of injectable naltrexone with TheraKine, it could make them a buyout target for Alkermes.

If you look at the last 2 PRs about FDA approval and the deal with TheraKine to produce injectable naltrexone, it has buy out written all over it. Only 500mm price tag on BICX would be $3 per share!

https://www.vivitrol.com/

https://finance.yahoo.com/quote/alks?ltr=1

JMHO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BICX News